Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C31H48O5 |
| Molecular Weight | 500.7098 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 3 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OC(=O)C(C)(C)[C@H](O)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C
InChI
InChIKey=AUMBXYDXKLLKEK-BGMQPCSBSA-N
InChI=1S/C31H48O5/c1-19(2)36-29(35)30(5,6)28(34)15-10-20(3)25-13-14-26-22(9-8-16-31(25,26)7)11-12-23-17-24(32)18-27(33)21(23)4/h10-12,15,19-20,24-28,32-34H,4,8-9,13-14,16-18H2,1-3,5-7H3/b15-10+,22-11+,23-12-/t20-,24-,25-,26+,27+,28-,31-/m1/s1
| Molecular Formula | C31H48O5 |
| Molecular Weight | 500.7098 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 3 |
| Optical Activity | UNSPECIFIED |
Tisocalcitate is the vitamin D derivative. Tisocalcitate ointment is currently in phase 2 clinical development for mild to moderate psoriasis. Early studies have shown that, unlike other vitamin D3 analogues, tisocalcitate does not affect calcium metabolism. Tisocalcitate ointments were tolerated well and were safe to use on healthy skin. Tisocalcitate had been in phase II clinical trial for the treatment of psoriasis. However, this development was discontinued.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:33:22 GMT 2025
by
admin
on
Wed Apr 02 07:33:22 GMT 2025
|
| Record UNII |
8O4QYK6G4Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C39713
Created by
admin on Wed Apr 02 07:33:22 GMT 2025 , Edited by admin on Wed Apr 02 07:33:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C66606
Created by
admin on Wed Apr 02 07:33:22 GMT 2025 , Edited by admin on Wed Apr 02 07:33:22 GMT 2025
|
PRIMARY | |||
|
8375
Created by
admin on Wed Apr 02 07:33:22 GMT 2025 , Edited by admin on Wed Apr 02 07:33:22 GMT 2025
|
PRIMARY | |||
|
156965-06-9
Created by
admin on Wed Apr 02 07:33:22 GMT 2025 , Edited by admin on Wed Apr 02 07:33:22 GMT 2025
|
PRIMARY | |||
|
RR-02
Created by
admin on Wed Apr 02 07:33:22 GMT 2025 , Edited by admin on Wed Apr 02 07:33:22 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104989
Created by
admin on Wed Apr 02 07:33:22 GMT 2025 , Edited by admin on Wed Apr 02 07:33:22 GMT 2025
|
PRIMARY | |||
|
8O4QYK6G4Y
Created by
admin on Wed Apr 02 07:33:22 GMT 2025 , Edited by admin on Wed Apr 02 07:33:22 GMT 2025
|
PRIMARY | |||
|
300000034423
Created by
admin on Wed Apr 02 07:33:22 GMT 2025 , Edited by admin on Wed Apr 02 07:33:22 GMT 2025
|
PRIMARY | |||
|
9913924
Created by
admin on Wed Apr 02 07:33:22 GMT 2025 , Edited by admin on Wed Apr 02 07:33:22 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|